Raw Data Library
About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User Guide
Green Science
​
​
EN
Kurumsal BaşvuruSign inGet started
​
​

About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User GuideGreen Science

Language

Kurumsal Başvuru

Sign inGet started
RDL logo

Verified research datasets. Instant access. Built for collaboration.

Navigation

About

Aims and Scope

Advisory Board Members

More

Who We Are?

Contact

Add Raw Data

User Guide

Legal

Privacy Policy

Terms of Service

Support

Got an issue? Email us directly.

Email: info@rawdatalibrary.netOpen Mail App
​
​

© 2026 Raw Data Library. All rights reserved.
PrivacyTermsContact
  1. Raw Data Library
  2. /
  3. Publications
  4. /
  5. Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence matters

Verified authors • Institutional access • DOI aware
50,000+ researchers120,000+ datasets90% satisfaction
Editorial Material
en
2024

Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence matters

0 Datasets

0 Files

en
2024
Vol 26 (4)
Vol. 26
DOI: 10.1111/bdi.13435

Get instant academic access to this publication’s datasets.

Create free accountHow it works

Frequently asked questions

Is access really free for academics and students?

Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.

How is my data protected?

Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.

Can I request additional materials?

Yes, message the author after sign-up to request supplementary files or replication code.

Advance your research today

Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.

Get free academic accessLearn more
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
Access Research Data

Join our academic network to download verified datasets and collaborate with researchers worldwide.

Get Free Access
Institutional SSO
Secure
This PDF is not available in different languages.
No localized PDFs are currently available.
Eduard Vieta
Eduard Vieta

Institution not specified

Verified
Lakshmi N. Yatham
Ayal Schaffer
Lars Vedel Kessing
+5 more

Abstract

Yatham LN: reports consultant/speaker fees from Alkermes, Allergan (currently Abbvie) Dainippon Sumitomo Pharma, Gedeon Richter, GSK, Intracellular Therapies, Merck, Sanofi, and Sunovion, and grants from Allergan (now AbbVie), CIHR, and Dainippon Sumitomo, outside the submitted work, over the last 3 years. Schaffer A has received consultant/speaker fees from Allergan/Abbvie, GSK, Lundbeck, Otsuka in the past 3 years. Kessing LV has been a consultant for Teva and Lundbec during the last 3 years. Miskowiak KW reports consultancy fees from Lundbeck, Angelini, Gedeon Richter, and Janssen-Cilag in the past 3 years. Kapczinski F received grants or participated in the board or as speaker for the following entities: Johnson & Johnson, Daiichi Sankyo, Ache, and Janssen. Vieta E has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, AbbVie, Adamed, Angelini, Biogen, Biohaven, Boehringer-Ingelheim, Celon Pharma, Compass, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Idorsia, Johnson & Johnson, Lundbeck, Medincell, Merck, Newron, Novartis, Orion Corporation, Organon, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, and Viatris, outside the submitted work. Post RM: Speaker for Sunovion and Abbvie. Berk M: Grant/Research Support: MRFF, NHMRC, Congressionally Directed Medical Research Programs (CDMRP) USA, AEDRTC Australian Eating Disorders Research and Translation Centre, Patient-Centered Outcomes Research Institute (PCORI), Baszucki Brain Research Fund, Danmarks Frie Forskningsfond. Psykiatrisk Center Kobenhavn, Stanley Medical Research Institute, Victorian Government Department of Jobs, Precincts and Regions, Wellcome Trust, Victorian Medical Research Acceleration Fund, Controversias Psiquiatria Barcelona, CRE, Victorian COVID-19 Research Fund, Consultancies: Lundbeck, Sandoz, Servier, Medisquire, HealthEd, ANZJP, EPA, Janssen, Medplan, RANZCP, Abbott India, ASCP, International Society of Bipolar Disorder, Precision Psychiatry, Penn State College of Medicine, Shanghai Mental Health Centre. (Last 3 years)—all unrelated to this work. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

How to cite this publication

Lakshmi N. Yatham, Ayal Schaffer, Lars Vedel Kessing, Kamilla Woznica Miskowiak, Flávio Kapczinski, Eduard Vieta, Robert M. Post, Michael Berk (2024). Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence matters. , 26(4), DOI: https://doi.org/10.1111/bdi.13435.

Related publications

Why join Raw Data Library?

Quality

Datasets shared by verified academics with rich metadata and previews.

Control

Authors choose access levels; downloads are logged for transparency.

Free for Academia

Students and faculty get instant access after verification.

Publication Details

Type

Editorial Material

Year

2024

Authors

8

Datasets

0

Total Files

0

Language

en

DOI

https://doi.org/10.1111/bdi.13435

Join Research Community

Access datasets from 50,000+ researchers worldwide with institutional verification.

Get Free Access